三环皮里达津基分子的治疗潜力:概述
Battistina Asproni1, Gérard A Pinna1, Paola Corona1
1Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni 23/A, 07100 Sassari, Italy.
International journal of molecular sciences
|May 7, 2025
概括
皮里达津-3(2H) - 一化合物是药物化学中的多功能支架,表现出多样化的药理学活性. 本综述侧重于用于治疗应用的三环二酸衍生物的结构活性关系 (SAR) 研究.
科学领域:
- 药用化学 医学化学
- 有机化学 有机化学
- 药理学 药理学 是一个学科.
背景情况:
- 皮里达津-3(2H) - 一衍生物因其广泛的药理学潜力而得到认可.
- 这些异环化合物作为各种治疗剂的核心结构.
研究的目的:
- 审查三环金基化合物的结构活性关系 (SAR) 研究.
- 要突出与这些支架相关的多样化的生物和治疗性质.
主要方法:
- 关于pyridazinone衍生物的SAR研究的文献综述.
- 分析已公布的关于合成和生物评估的多环形化的数据.
主要成果:
- 三环化化支架显示出广泛的药理学效应.
- SAR研究揭示了影响抗炎,抗癌和心血管保护等活动的关键结构特征.
结论:
- 基于pyridazinone的多环化合物是药物开发的有希望的候选者.
- 进一步的SAR研究可以优化这些分子的治疗潜力.
相关概念视频
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
233
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
233
Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
Antidepressant Drugs: MAOIs and Other Agents
163
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
163
Drugs Affecting Neurotransmitter Release or Uptake
872
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
872
Sedatives and Hypnotics Drugs: Miscellaneous Agents
119
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
119
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
176
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
176


